High-dose immunoglobulin therapy for steroid-resistant myositis in juvenile localized scleroderma

Pediatr Neonatol. 2022 Sep;63(5):542-544. doi: 10.1016/j.pedneo.2022.01.006. Epub 2022 Apr 1.

Authors

Motoshi Sonoda¹, Masataka Ishimura², Katsuhide Eguchi¹, Akira Shiraishi¹, Yasunari Sakai¹, Kazunori Urabe³, Shouichi Ohga¹

Affiliations

¹ Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
² Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Electronic address: ischii-pediatr@kyudai.jp.
³ Department of Dermatology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.

PMID: 35803858
DOI: 10.1016/j.pedneo.2022.01.006

No abstract available

MeSH terms

Humans
Immunization, Passive
Myositis*
Scleroderma, Localized* / drug therapy
Steroids / therapeutic use

Substances

Steroids